[3] Tada Y, Wada M, Migita T, et al. Increased expression of multidrug resistance associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin[J]. Int J Cancer，2002 ,98 (4) : 630 -635.
[4] Hsu CH， Chen CL， Hong RL，et al. Prognostic value of multidrug resistance 1, glutathione-S-Transferase-[pi] and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy[J]. Oncology，2002,62(4)：305-312.
[5] Sharma V, Prior JL, Belinsky MG, et al. Characterization of a sup 67Ga/sup 68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo:validation in multidrug-resistant tumors and at the blood-brain barrier[J]. J Nucl Med，2005,46(2):354-364.
[6] Rittierodt M, Tschernig T, Harada K. Modulation of multidrug-resistance-associated P-glycoprotein in human U-87 MG and HUV-ECC cells with antisense oligodeoxynucleotides to MDR1 mRNA[J]. Pathobiology, 2004,71(3):123-128.
[7] Borowski E, Bontemps-Gracz MM, Piwkowska A. Strategies for overcoming ABC-transporters-mediated multidrug resistance(MDR) of tumor cells[J]. Acta Biochim Pol，2005,52(3)：609-627.
[8] Akan I，Akan S，Akca H，et al. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and buthionine sulfoximine[J]. Cancer Cell Int，2005,5(1):22-30.
[9] Laochariyakul P， Ponglikitmongkol M，Mankhetkorn S. Functional study of intracellular P-gp-and MRP1-mediated pumping of free cytosolic pirarubicin into acidic organelles in intrinsic resistant SiHa cells[J]. Can J Physiol Pharmacol，2003,81(8)：790-799.
[10] Ohsawa M ，Ikura Y，Fukushima H, et al. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma[J]. Oncology，2005,68(4-6):422-431.
[11] Harada T, Ogura S, Yamazaki K, et al. Predictive value of expression of p53, bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers[J]. Cancer Sci，2003, 94(4):394-399.
[12] Yeh JJ,Hsu NY,Hsu WH, et al. Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer[J]. Lung，2005,183(3):177-183.
[13] Chiou JF, Liang JA, Hsu WH, et al. Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer[J]. Lung，2003,181(5):267-273.
[14] Burger H, van Tol H, Brok M, et al.Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps[J]. Cancer Biol
Ther，2005,4(7):747-752.
[15] Guo B, Villeneuve DJ, Hembruff SL, et al. Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure[J]. Breast Cancer Res Treat，2004,85(1):31-51.
[16] Ee PL, He X, Ross DD, et al. Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference[J]. Mol Cancer Ther，2004,3(12):1577-1583.
[17] Raaijmakers MH, de Grouw EP, Heuver LH, et al. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia[J]. Clin Cancer Res，2005,11(6):2436-2444.
[18] Kowalski P, Surowiak P, Lage H. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP[J]. Mol Ther，2005,11(4):508-522.
[19] Goto S, Kamada K, Soh Y, et al. Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs[J]. Jpn J Cancer Res， 2002 ,93(9):1047-1056.
[20] Giri U, Terry NH, Kala SV, et al. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28) [J]. Cancer Chemother Pharmacol, 2005,55（6）：511-521.
转贴于 酷文网-论文下载中心 http://www.coolwen.net
共3页: 上一页 [1] [2] 3 下一页
网摘收藏:
当前位置:
载入中...
-> 在百度中搜索：
-> 在Google中搜索：